SCHOUW + CO financials
SCHOUW + CO
Country: DK Reporting currency: EUR Latest annual report: 2026-06-30
LEI:
213800V2R9WMMZASKK57 ISIN: DK0010253921 Financial statements
(EUR, as reported — unscaled; 101 line items across 4 annual periods)
| Line item | 2026 | 2025-12-31 | 2025-06-30 | 2024 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | €16.66B | €34.13B | €16.45B | — |
| Other income | €19.0M | €89.0M | €42.0M | — |
| Operating profit (EBIT) | €836.0M | €1.45B | €715.0M | — |
| Finance costs | €291.0M | €503.0M | €405.0M | — |
| Profit before tax | €731.0M | €1.15B | €521.0M | — |
| Income tax expense | €210.0M | €441.0M | €156.0M | — |
| Profit for the year | €521.0M | €707.0M | €365.0M | — |
| — attributable to owners | €486.0M | €650.0M | €347.0M | — |
| — attributable to NCI | €35.0M | €57.0M | €18.0M | — |
| Total comprehensive income | €777.0M | €228.0M | -€177.0M | — |
| Per share | ||||
| Basic EPS | €21.44 | €28.41 | €15.12 | — |
| Diluted EPS | €21.37 | €28.35 | €15.10 | — |
| Cash flow statement | ||||
| Cash generated from operations | €832.0M | €3.62B | €1.15B | — |
| Net cash from operating activities | €436.0M | €2.90B | €762.0M | — |
| Income taxes paid | €262.0M | €456.0M | €241.0M | — |
| Net cash from investing activities | -€2.30B | -€592.0M | -€250.0M | — |
| Purchase of PP&E (capex) | €311.0M | €569.0M | €284.0M | — |
| Purchase of intangibles | €11.0M | €39.0M | €18.0M | — |
| Net cash from financing activities | €2.11B | -€1.89B | -€287.0M | — |
| Dividends paid | €389.0M | €388.0M | €378.0M | — |
| Net change in cash | €246.0M | €415.0M | €225.0M | — |
| Balance sheet | ||||
| Total assets | €30.73B | €26.98B | €27.66B | €28.12B |
| Non-current assets | €12.06B | €12.02B | €12.18B | €12.72B |
| Property, plant & equipment | €6.23B | €6.14B | €6.14B | €6.38B |
| Right-of-use assets | €843.0M | €936.0M | €735.0M | €796.0M |
| Intangible assets & goodwill | €3.87B | €3.89B | €4.27B | €4.42B |
| Current assets | €18.66B | €14.96B | €15.48B | €15.40B |
| Inventories | €7.34B | €6.64B | €6.94B | €7.25B |
| Trade & other receivables | €7.61B | €6.88B | €7.32B | €7.12B |
| Cash & equivalents | €1.54B | €1.25B | €1.05B | €892.0M |
| Total equity | €14.80B | €11.80B | €11.60B | €12.23B |
| — attributable to owners | €13.56B | €11.31B | €10.70B | €11.28B |
| Non-controlling interests | €1.24B | €492.0M | €895.0M | €954.0M |
| Non-current liabilities | €4.29B | €6.12B | €6.46B | €5.84B |
| Long-term borrowings | €3.48B | €4.79B | €5.18B | €4.62B |
| Current liabilities | €11.64B | €9.06B | €9.60B | €10.05B |
| Trade & other payables | €8.34B | €7.64B | €7.54B | €7.58B |
| Deferred tax liabilities | €551.0M | €501.0M | €530.0M | €503.0M |
| Derived metrics | ||||
| Free cash flow | €125.0M | €2.33B | €478.0M | — |
| Operating margin | 5.0% | 4.2% | 4.3% | — |
| Net margin | 3.1% | 2.1% | 2.2% | — |
| Return on equity | 3.5% | 6.0% | 3.1% | — |
| Cash conversion ratio | 0.84× | 4.10× | 2.09× | — |
| Capex coverage | 1.40× | 5.09× | 2.68× | — |
| Other reported items | ||||
| Adjustments For Provisions | -€23.0M | -€21.0M | €1.0M | — |
| Cash Advances and Loans From Related Parties | €2.62B | €0 | €0 | — |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €0 | €124.0M | €29.0M | — |
| Cash Flows From Used In Increase Decrease In Current Borrowings | €457.0M | €1.13B | €372.0M | — |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €21.0M | €68.0M | €68.0M | — |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €33.0M | €26.0M | €0 | — |
| Comprehensive Income Attributable To Noncontrolling Interests | €56.0M | -€15.0M | -€47.0M | — |
| Comprehensive Income Attributable To Owners of Parent | €720.0M | €243.0M | -€130.0M | — |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €2.55B | €1.17B | €1.50B | €1.82B |
| Current Tax Assets Current | €170.0M | €186.0M | €173.0M | €143.0M |
| Current Tax Liabilities Current | €201.0M | €253.0M | €165.0M | €202.0M |
| Deferred Tax Assets | €228.0M | €188.0M | €229.0M | €177.0M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €583.0M | €1.43B | €556.0M | — |
| Dividends Received From Investments Accounted For Using Equity Method Classified As Investing Activities | €0 | €18.0M | €0 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €42.0M | -€53.0M | -€64.0M | — |
| Equity and Liabilities | €30.73B | €26.98B | €27.66B | €28.12B |
| Finance Income | €162.0M | €149.0M | €186.0M | — |
| Gains Losses On Cash Flow Hedges Before Tax | €32.0M | €20.0M | €4.0M | — |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €4.0M | €9.0M | €0 | — |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €0 | -€3.0M | €0 | — |
| Increase Decrease In Working Capital | €589.0M | -€810.0M | €95.0M | — |
| Increase Decrease Through Acquisition of Subsidiary | €0 | — | — | — |
| Increase Decrease Through Sharebased Payment Transactions | €2.0M | — | €4.0M | — |
| Increase Decrease Through Transactions With Owners | €2.22B | — | -€458.0M | — |
| Interest Paid Classified As Operating Activities | €187.0M | €370.0M | €189.0M | — |
| Interest Received Classified As Operating Activities | €53.0M | €107.0M | €46.0M | — |
| Investments In Associates Accounted For Using Equity Method | €383.0M | €368.0M | €348.0M | €417.0M |
| Investments In Joint Ventures Accounted For Using Equity Method | €275.0M | €237.0M | €225.0M | €226.0M |
| Issued Capital | €250.0M | €250.0M | €250.0M | €250.0M |
| Liabilities | €15.93B | €15.18B | €16.06B | €15.89B |
| Noncurrent Financial Assets | €3.0M | €5.0M | €4.0M | €95.0M |
| Noncurrent Loans and Receivables | €232.0M | €246.0M | €232.0M | €212.0M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €85.0M | €86.0M | €74.0M | €78.0M |
| Other Adjustments For Noncash Items | €26.0M | -€54.0M | -€31.0M | — |
| Other Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | -€1.0M | €3.0M | €1.0M | — |
| Other Comprehensive Income | €256.0M | -€479.0M | -€543.0M | — |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €208.0M | -€461.0M | -€534.0M | — |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €0 | -€20.0M | €0 | — |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €256.0M | -€462.0M | -€543.0M | — |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | €0 | -€17.0M | €0 | — |
| Other Expense By Nature | €2.0M | €11.0M | €1.0M | — |
| Other Noncurrent Liabilities | €170.0M | €163.0M | €164.0M | €157.0M |
| Payments To Acquire Or Redeem Entitys Shares | €242.0M | €370.0M | €284.0M | — |
| Proceeds From Noncurrent Borrowings | €0 | €2.0M | -€24.0M | — |
| Proceeds From Sale Or Issue of Treasury Shares | €92.0M | €181.0M | €181.0M | — |
| Proceeds From Sales of Interests In Associates | -€2.74B | — | — | — |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €8.0M | €78.0M | €47.0M | — |
| Purchase of Interests In Associates | -€1.0M | €11.0M | -€4.0M | — |
| Purchase of Treasury Shares | €267.0M | — | €284.0M | — |
| Repayments of Noncurrent Borrowings | €477.0M | €1.99B | €154.0M | — |
| Reserve of Cash Flow Hedges | €12.0M | -€8.0M | -€11.0M | -€5.0M |
| Reserve of Exchange Differences On Translation | -€21.0M | -€237.0M | -€314.0M | €157.0M |
| Retained Earnings | €13.32B | €10.88B | €10.78B | €10.48B |
| Sale Or Issue of Treasury Shares | €117.0M | — | €181.0M | — |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Before Tax | €0 | -€1.0M | €0 | — |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €4.0M | €7.0M | -€1.0M | — |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | €19.0M | €49.0M | €26.0M | — |
Methodology
Every line item above is a fact tagged in SCHOUW + CO's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.